Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 04, 2015 10:34 AM ET

Electronic Equipment, Instruments and Components

Company Overview of Schott AG

Company Overview

SCHOTT AG, together with its subsidiaries, develops and manufactures specialty glasses, special materials, components, and systems in Germany and internationally. It operates through three segments: Precision Materials, Optical Industries, and Home Appliances. The company offers glasses, special materials, and components for optics, lithography, astronomy, opto-electronics, architecture, life sciences, and research applications; architectural glasses for exterior and interior applications; and receivers for use as components for concentrated solar power plants. It also provides hermetic housings and other components for electronic packaging; lighting and imaging systems for use in architectu...

Hattenbergstrasse 10

Mainz,  55122


Founded in 1884

15,444 Employees


49 6131 66 0


49 6131 66 2000

Key Executives for Schott AG

Chairman of Management Board
Age: 51
Executive Vice President and General Executive
Age: 58
Deputy Chairman of Supervisory Board, Chairman of The Employees Council, Member of Conference Committee and Member of Presiding Committee
Vice President of Services - Mainz
General Executive and Member of The Corporate Management Committee
Compensation as of Fiscal Year 2014.

Schott AG Key Developments

SCHOTT AG Introduces New Polymer Prefillable Syringe System for Sensitive Drugs

SCHOTT AG has introduced SCHOTT TopPac SD, a new polymer prefillable syringe system designed to enhance the safety and stability of sensitive drugs, or SD. As pharma companies are looking for safe and reliable packaging solutions, the new product named SCHOTT TopPac SD offers new features for a reduced E&L (extractables and leachables) profile. Through specific component selection and an optimized processing method, SCHOTT TopPac SD offers a significantly reduced level of impurities, decreasing the chance of drug/container interaction. The syringe features an inert COC barrel (cyclic olefin copolymer) that releases no ions or heavy metals, and reduces the chances of a chemical interaction with sensitive drugs. Additionally, the PFS (prefilled syringe) was developed with pure elastomer components in order to reduce the E&L profile. Cross-linked silicone for barrel lubrication reduces the amount of subvisible particles with optimal functionality. Finally, the new syringes are sterilized with an ETO (Ethylene Oxide) sterilization method, rather than irradiation, to further reduce the E&L profile. While the new product features a number of components that were specially designed to house sensitive drugs, the PFS also retains the traditional advantages of the TopPac product line, including glass-like transparency, an integrated Luer Lock system, standardized tub-and-nest offerings, and compatibility with needleless IV connectors.

SCHOTT AG Expands Design Portfolio of to Packages

SCHOTT AG has expanded its design portfolio of TO packages for the 10GBit/sec range. The new SCHOTT TEC TO package enables the development of high-speed data transfer in the tele- and data communications market and is ideal for 10GBit/s laser diodes that require a thermoelectric cooler (TEC), enabling its application in middle to long distances. Since the package is based on a TO footprint, it is also reduced in size compared to the conventional box packages. When designing a TO package for high-frequency applications, impedance matching and space constraints pose the larger challenge to the developer. SCHOTT has overcome these limitations with the new TEC TO design. The thermoelectric cooler allows for controlled heat dissipation, which leads to regulated and stable laser wave lengths. The new design is also based on an extended radio-frequency feed through, which boasts shortened wire-bonds to minimize signal losses to the laser diode, thereby improving the overall performance. In addition, the new TEC TO is a package design based on a well-conducting steel platform that no longer relies on the box design.

Schott Expands PURAVIS Product Family to Include Rigid Fiber Rods

SCHOTT has expanded its PURAVIS product family to include rigid fiber rods for use in dental devices. Rigid fiber optic solutions are particularly well suited for use in dental instruments such as straight and contra-angle handpieces and polymerization units. Powerful light can thus be placed where only little space is available for illumination. Thanks to yet other improved material properties, PURAVIS fibers open up new application areas. The transmission that has been extended in the blue wavelength range allows for integration of applications such as caries or cancer screening based on fluorescence diagnostics. Thanks to a major development, SCHOTT is now able to present its customers new areas of application for PURAVIS optical fibers: rigid fiber rods for dental applications are now available. Due to an acceptance angle of up to 85° and thus more than in conventional materials considerably more light can be absorbed by the fiber and thus transmitted. In this way, higher light output can be achieved while maintaining the same size of the light source. Alternatively, the devices can be made smaller and electrical resources can be reduced in order to obtain the same optical power. Furthermore, device developers have more freedom in designing the light source because efficient coupling can be ensured even with complex constructions. The PURAVIS fiber rod offers much more than just lighting, however. Improved transmission properties in the blue wavelength range, i.e. near UV light waves, allow for wavelengths to be transmitted that could not have been transmitted before. Power reserves can thus be used and more powerful products can be developed. Moreover, additional functions can be integrated into the device. This includes, for example, diagnostic functions such as cancer or caries detection based on the latest fluorescence diagnostics. The special glass formula of SCHOTT fibers has a high resistance class and thus ensures the excellent long-term stability of PURAVIS fibers. The fibers can therefore be cleaned, disinfected and sterilized repeatedly without diminishing the quality of light transmission. SCHOTT manufactures its lead-free PURAVIS glass fibers in a patented, environmentally friendly production process without using arsenic or antimony. Therefore, they already comply with future requirements of the RoHS Directive. The production process is thus in line with the company's commitment to protecting the environment.

Similar Private Companies By Industry

Company Name Region
STEAG Powitec GmbH Europe
Elprog Gmbh Europe
MSI Technology GmbH Europe
SLS Solar Line Saxony GmbH Europe
Vincotech GmbH Europe

Recent Private Companies Transactions

December 5, 2014
Schott Moritex Corporation

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Schott AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at